Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice
Neuroscience Letters · 2024
DOI: 10.1016/j.neulet.2024.137828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroscience Letters, 2024. Verfasst von Fernanda Daher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Antidepressive Agents, Receptors, GABA-A. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Abstract (Originalsprache)
There is a critical need for safer and better-tolerated alternatives to address the current limitations of antidepressant treatments for major depressive disorder. Recently, drugs targeting the GABA system via α5-containing GABAA receptors (α5-GABAAR) as negative allosteric modulators (α5-NAMs) have shown promise in alleviating stress-related behaviors in preclinical studies, suggesting that α5-NAMs may have translational relevance as novel antidepressant medications. Here, we evaluated the efficacy of Basmisanil, an α5-NAM that has been evaluated in Phase 2 clinical studies as a cognitive enhancer, in a battery of behavioral tests relevant to coping strategies, motivation, and aversion in male mice, along with plasma and brain pharmacokinetic measurements. Our findings reveal that Basmisanil induces dose-dependent rapid antidepressant-like responses in the forced swim test and sucrose splash test without promoting locomotor stimulating effects. Furthermore, Basmisanil elicits sustained behavioral responses in the female urine sniffing test and sucrose splash test, observed 24 h and 48 h post-treatment, respectively. Bioanalysis of plasma and brain samples confirms effective blood-brain barrier penetration by Basmisanil and extrapolation to previously published data suggest that effects were observed at doses (10 and 30 mg/kg i.p.) corresponding to relatively modest levels of α5-GABAAR occupancy (40-65 %). These results suggest that Basmisanil exhibits a combination of rapid and sustained antidepressant-like effects highlighting the potential of α5-NAMs as a novel therapeutic strategy for depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
- Medicines Discovery Institute, Cardiff University, Park Place, CF10 3AT, Cardiff, Wales, United Kingdom.
- Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA. Electronic address: manoela_fogaca@urmc.rochester.edu.
Förderung
- NIMH NIH HHS
Zitieren
APA
Daher, F., Villalobos, N. A., Hanley, M., Atack, J. R., Popa, M. O., & Fogaça, M. V. (2024). Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2024.137828
Vancouver
Daher F, Villalobos NA, Hanley M, Atack JR, Popa MO, Fogaça MV. Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice. Neuroscience Letters. 2024. doi:10.1016/j.neulet.2024.137828
BibTeX
@article{Daher2024,
author = {Daher, Fernanda and Villalobos, Narcy A and Hanley, Marcus and Atack, John R and Popa, Mariana O and Fogaça, Manoela V},
title = {Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice},
journal = {Neuroscience Letters},
year = {2024},
doi = {10.1016/j.neulet.2024.137828}
}
EUVIMED